| Application no. and date | 19175120.5 (espacenet) (Federated) (European Patent Register), 20090226 | | Patent/reg. no. and date | DK/EP 3578169, 20240626 | | Publication date | 20191211 | | Priority no. and date | | | EP pub. no. and date |
EP 3578169 20191211 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage, SG1 2NY, United Kingdom, GB | | Applicant ref. no. | V477375DK00 | | Inventor | BRUCE, Mark, GlaxoSmithKline
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
BAKER, Darrell, GlaxoSmithKline
Stockley Park West
Uxbridge, Middlesex UB11 1BT, GB,
THOMAS, Marian, GlaxoSmithKline
Park Road
Ware, Hertfordshire SG12 ODP, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/138 (2006.01) , A61K 31/58 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 11/00 (2006.01) , A61P 11/06 (2006.01) , A61P 11/08 (2006.01) , A61P 37/08 (2006.01) , A61P 43/00 (2006.01) | | Title | Farmaceutiske formuleringer omfattende 4-{(1R)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
